BG
LUNG icon

Bellevue Group’s Pulmonx LUNG Stock Holding History

Bellevue Group’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-173,336
Closed -$2.89M – 174
2022
Q3 		$2.89M Hold
173,336
– – 0.04% 116
2022
Q2 		$2.55M Sell
173,336
-3,174
-2% -$65.4K 0.04% 123
2022
Q1 		$4.38M Hold
176,510
– – 0.05% 120
2021
Q4 		$5.66M Hold
176,510
– – 0.06% 122
2021
Q3 		$6.35M Hold
176,510
– – 0.06% 127
2021
Q2 		$7.79M Hold
176,510
– – 0.08% 126
2021
Q1 		$8.07M Hold
176,510
– – 0.09% 124
2020
Q4 		$12.2M Buy
+176,510
New +$8.64M 0.14% 112

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Bellevue Group's LUNG Position: Q4 2022 in Review

Bellevue Group sold out of Pulmonx (LUNG) in Q4 2022, closing a stake of 173,336 shares — an estimated $2.89M sold.

Bellevue Group first reported a position in LUNG in Q4 2020 and held it in 8 quarters. The position peaked at $12.2M in Q4 2020. 116 funds tracked by Wall St. Rank hold LUNG as of Q4 2022.

  • Bellevue Group reported no remaining Pulmonx position as of Q4 2022 after selling out during the quarter.
  • Bellevue Group sold 173,336 Pulmonx shares in Q4 2022, an estimated $2.89M.
  • Bellevue Group first reported a position in Pulmonx in Q4 2020 and held it in 8 quarters.
  • Bellevue Group's Pulmonx position peaked at $12.2M in Q4 2020.
  • 116 funds tracked by Wall St. Rank held Pulmonx as of Q4 2022.

Based on Bellevue Group's 13F filing for Q4 2022, filed 14 Feb 2023.